Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Submitted by
admin
on July 14, 2017 - 7:54am
Source:
Fierce Pharma
News Tags:
Amgen
Kyprolis
Revlimid
Celgene
Takeda
Velcade
Multiple Myeloma
Headline:
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Do Not Allow Advertisers to Use My Personal information
